14-09-2018
Dr. med. Alexander Samol presents iVAC 2L first German study results at TCT 2018
In 17 patients (3 female, age 73±9 years, left ventricular ejection fraction (LVEF) 45±12%) high-risk PCI (complex left main PCI n=8, PCI of last remaining vessel n=1, complex PCI in severe three-vessel disease and reduced LVEF n=8) was performed underuse of the iVAC 2L system, a new trans-femoral pulsatile assist device with up to 2l additional cardiac output. Before and after device placement as well as immediately after PCI aortic and intracoronary pressure data were collected
View Poster – IVACTCTPOSTERWindows
